News

South Korea to begin first clinical trial for COVID-19

South Korea’s International Vaccine Institute (IVI) and Seoul National University Hospital will soon be administering the country’s first-ever clinical trials for the vaccine against the coronavirus disease (COVID-19).
The two entities have partnered with pharmaceutical company Inovio to test the vaccine currently known as INO-4800 in its first and second phases.
“South Korea is one of the first countries in the world set to test a COVID-19 vaccine (after the United States, China, United Kingdom and Germany). The trials are a crucial step in the development of an urgently needed vaccine,” said IVI Director-General Dr. Jerome Kim during a signing ceremony held June 4 at the Seoul National University Hospital, as per The Korea Herald.
RELATED STORY: Pfizer eyes availability of COVID-19 vaccine by October 2020
During the first phase, 40 healthy adults whose ages range from 19-50 will be administered with the vaccine. The second phase will see 120 people aged 19-64 to determine the vaccine’s viability, immunogenicity, and overall tolerability of South Korea’s residents to the vaccine.
SNU Hospital frontliner and clinical trial lead Dr. Oh Myoung-don stated that this marks a significant milestone for the country towards achieveing its post-COVID-19 normalcy.
“Prolonging physical distancing cannot be sustainable. Hopes of a vaccine allow us to envision a return to normal life,” said Dr. Oh Myoung-don as per The Korea Herald.
READ ON: Russia to begin providing approved COVID-19 drug on June 11

Staff Report

The Filipino Times is the chronicler of stories for, of and by Filipinos all over the world, reaching more than 236 countries in readership. Any interesting story to share? Email us at [email protected]

Related Articles

Back to top button